+44 (0) 20 7549 9987 | USA callers: +1 212 220 8419

Contact Us Now

“Amniotic Membrane Market Report is set to have rapid growth due the rising awareness and the presence of technologically advanced countries in terms of healthcare and medical research at global, regional and national level, influencing the industry trends in each of the sub-segments from 2019 to 2029”

04 September 2019
Pharma

Visiongain has launched a new pharma report Amniotic Membrane Market Report : Forecast By End Use (ASC, Hospital), By Enzyme (Dehydrated, Cryopreserved), By Application (Ophthalmology, Surgical Wounds), Region and Segment Forecasts

The global Amniotic Membrane market is poised for rapid growth between 2019 and 2029. The growing awareness in the recent past has led to an increase in the number of transplants which has led to a growing demand for these tissue-based products. It has also led to an increase in the number of donations, thus fueling market growth.

The main factors driving the growth of the amniotic membrane market is the increase in the geriatric population combined with the increase in transplantation based on the amniotic membrane at the global level. However, the lack of qualified professionals and the high cost of surgical interventions involving the amniotic membrane slow the growth of the global amniotic membrane market. Furthermore, increasing awareness of the potential benefits of the amniotic membrane between patients and healthcare professionals offers profitable opportunities that promote the market.

Leading companies featured in the report include Alliqua BioMedical, Inc.; Amnio Technology, LLC; Applied Biologics LLC; Human Regenerative Technologies, LLC; DermaSciences; Katena Products, Inc.; MiMedx Group, Inc.; Skye Biologics, Inc.; Amniox Medical, Inc.; and Organogensis, Inc.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034

The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.

23 April 2024

Read

Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.

18 April 2024

Read

Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.

17 April 2024

Read

Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

12 April 2024

Read